Regenerating.
Rewiring.
Recovering.

We have an ambitious long-term goal – Reverse the devastating effects of nervous system injuries. Finally. Our technology to achieve this is a next generation of therapy, ExoTherapy. ExoTherapies use exosomes as nanocarriers to deliver therapeutic molecules in the body creating a healing environment through neuron rewiring and regeneration. Almost anywhere. NurExosone’s first drug is targeting acute spinal cord injury. The company’s proprietary drug reversed paralysis in laboratory rats, enabling them to walk again. ExoPTEN. We believe we can transfer this amazing achievement to a drug for humans. And more. As we push the edge of medicine and biology, our ExoTherapy platform technology for producing and loading quality exosomes will incorporate new, exciting technologies and IP that may be licensed and spun off for other applications, and indications, driving early revenues and creating value for shareholders. Join us.